The efficacy of commercial smartwatches with a blood pressure‐monitoring feature: A pilot randomized controlled trial

Purpose The purpose was to explore the efficacy of a commercial smartwatch with a blood pressure‐monitoring feature. Design A randomized controlled trial. Methods Sixty healthy young adults were recruited. Participants were randomly allocated to wear a commercial smartwatch, one with and one without...

Full description

Saved in:
Bibliographic Details
Published in:Journal of nursing scholarship 2022-05, Vol.54 (3), p.324-331
Main Authors: Yen, Hsin‐Yen, Huang, Wen‐Hsin
Format: Article
Language:English
Subjects:
awareness
Blood Pressure
Chronic illnesses
Clinical trials
Disease prevention
Efficacy
Health behavior
Health care
Health promotion
Health Status
Heart rate
Humans
Hypertension
Intervention
Obesity
Outdoor air quality
Physical activity
Pilot Projects
Prevention programs
Resting
Selfmanagement
Selfmonitoring
self‐management
Smartphones
Smartwatches
Social networks
Software
Time use
Wearable computers
Wearable Electronic Devices
wearable technology
Weight control
Young Adult
Young adults
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3530-9c267fc86cc9b7ebf4f8d496d3b4f0761d5b4c360119ca51232fa2422a51a16b3
cites cdi_FETCH-LOGICAL-c3530-9c267fc86cc9b7ebf4f8d496d3b4f0761d5b4c360119ca51232fa2422a51a16b3
container_end_page 331
container_issue 3
container_start_page 324
container_title Journal of nursing scholarship
container_volume 54
creator Yen, Hsin‐Yen
Huang, Wen‐Hsin
description Purpose The purpose was to explore the efficacy of a commercial smartwatch with a blood pressure‐monitoring feature. Design A randomized controlled trial. Methods Sixty healthy young adults were recruited. Participants were randomly allocated to wear a commercial smartwatch, one with and one without a blood pressure‐monitoring feature for 12 weeks. Data were collected using Omron HEM‐907, Inbody 270S, and the International Physical Activity Questionnaire. Findings Results revealed a significant effect and group‐by‐time interaction on diastolic blood pressure. After 12 weeks in participants who wore a smartwatch with a blood pressure‐monitoring feature, the systolic and diastolic blood pressure and resting heart rate had decreased. Conclusion Using commercial smartwatches with a blood pressure‐monitoring feature is a feasible approach to support self‐management, increase awareness, and promote physical activity for health promotion, obesity and chronic disease prevention. Clinical relevance Wearable technologies may be an innovative strategy for preventing high blood pressure by continuous self‐monitoring and healthy behavior modifications.
doi_str_mv 10.1111/jnu.12740
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2599073694</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2680354215</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-9c267fc86cc9b7ebf4f8d496d3b4f0761d5b4c360119ca51232fa2422a51a16b3</originalsourceid><addsrcrecordid>eNp1kc1OVDEYhhujEUQX3oBp4gYWB_rfqTtCBDQENrBuenpap5Oe07HtyWRccQlcI1diYdCFid30TfPkSb_vBeAjRse4nZPVNB9jIhl6BfYxZ7LjSKjXT5nITnAm9sC7UlYIIYElfQv2KJMKS4H3weZ26aDzPlhjtzB5aNM4umyDibCMJteNqXbpCtyEuoQG9jGlAa6zK2XO7vH-YUxTqCmH6Qf0ztT2-AWewnWIqcJspiGN4ZcbmnaqOcXYYs1N_h688SYW9-HlPgB3519vzy67q5uLb2enV52lnKJOWSKktwthreql6z3zi4EpMdCeedQmGHjPLBUIY2UNx4QSbwgjpGWDRU8PwOHOu87p5-xK1WMo1sVoJpfmoglXCkkqFGvo53_QVZrz1H6niVggyhnBvFFHO8rmVEp2Xq9zaIvaaoz0Uxu6taGf22jspxfj3I9u-Ev-WX8DTnbAJkS3_b9Jf7--2yl_A2uwlfQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2680354215</pqid></control><display><type>article</type><title>The efficacy of commercial smartwatches with a blood pressure‐monitoring feature: A pilot randomized controlled trial</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Wiley</source><source>Social Science Premium Collection</source><source>Sociology Collection</source><creator>Yen, Hsin‐Yen ; Huang, Wen‐Hsin</creator><creatorcontrib>Yen, Hsin‐Yen ; Huang, Wen‐Hsin</creatorcontrib><description>Purpose The purpose was to explore the efficacy of a commercial smartwatch with a blood pressure‐monitoring feature. Design A randomized controlled trial. Methods Sixty healthy young adults were recruited. Participants were randomly allocated to wear a commercial smartwatch, one with and one without a blood pressure‐monitoring feature for 12 weeks. Data were collected using Omron HEM‐907, Inbody 270S, and the International Physical Activity Questionnaire. Findings Results revealed a significant effect and group‐by‐time interaction on diastolic blood pressure. After 12 weeks in participants who wore a smartwatch with a blood pressure‐monitoring feature, the systolic and diastolic blood pressure and resting heart rate had decreased. Conclusion Using commercial smartwatches with a blood pressure‐monitoring feature is a feasible approach to support self‐management, increase awareness, and promote physical activity for health promotion, obesity and chronic disease prevention. Clinical relevance Wearable technologies may be an innovative strategy for preventing high blood pressure by continuous self‐monitoring and healthy behavior modifications.</description><identifier>ISSN: 1527-6546</identifier><identifier>EISSN: 1547-5069</identifier><identifier>DOI: 10.1111/jnu.12740</identifier><identifier>PMID: 34791761</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>awareness ; Blood Pressure ; Chronic illnesses ; Clinical trials ; Disease prevention ; Efficacy ; Health behavior ; Health care ; Health promotion ; Health Status ; Heart rate ; Humans ; Hypertension ; Intervention ; Obesity ; Outdoor air quality ; Physical activity ; Pilot Projects ; Prevention programs ; Resting ; Selfmanagement ; Selfmonitoring ; self‐management ; Smartphones ; Smartwatches ; Social networks ; Software ; Time use ; Wearable computers ; Wearable Electronic Devices ; wearable technology ; Weight control ; Young Adult ; Young adults</subject><ispartof>Journal of nursing scholarship, 2022-05, Vol.54 (3), p.324-331</ispartof><rights>2021 Sigma Theta Tau International</rights><rights>2021 Sigma Theta Tau International.</rights><rights>Copyright Blackwell Publishing Ltd. May 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-9c267fc86cc9b7ebf4f8d496d3b4f0761d5b4c360119ca51232fa2422a51a16b3</citedby><cites>FETCH-LOGICAL-c3530-9c267fc86cc9b7ebf4f8d496d3b4f0761d5b4c360119ca51232fa2422a51a16b3</cites><orcidid>0000-0002-9194-1783</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2680354215/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2680354215?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,12825,21373,21374,27901,27902,30976,33588,33589,34507,34508,43709,44091,73964,74382</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34791761$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yen, Hsin‐Yen</creatorcontrib><creatorcontrib>Huang, Wen‐Hsin</creatorcontrib><title>The efficacy of commercial smartwatches with a blood pressure‐monitoring feature: A pilot randomized controlled trial</title><title>Journal of nursing scholarship</title><addtitle>J Nurs Scholarsh</addtitle><description>Purpose The purpose was to explore the efficacy of a commercial smartwatch with a blood pressure‐monitoring feature. Design A randomized controlled trial. Methods Sixty healthy young adults were recruited. Participants were randomly allocated to wear a commercial smartwatch, one with and one without a blood pressure‐monitoring feature for 12 weeks. Data were collected using Omron HEM‐907, Inbody 270S, and the International Physical Activity Questionnaire. Findings Results revealed a significant effect and group‐by‐time interaction on diastolic blood pressure. After 12 weeks in participants who wore a smartwatch with a blood pressure‐monitoring feature, the systolic and diastolic blood pressure and resting heart rate had decreased. Conclusion Using commercial smartwatches with a blood pressure‐monitoring feature is a feasible approach to support self‐management, increase awareness, and promote physical activity for health promotion, obesity and chronic disease prevention. Clinical relevance Wearable technologies may be an innovative strategy for preventing high blood pressure by continuous self‐monitoring and healthy behavior modifications.</description><subject>awareness</subject><subject>Blood Pressure</subject><subject>Chronic illnesses</subject><subject>Clinical trials</subject><subject>Disease prevention</subject><subject>Efficacy</subject><subject>Health behavior</subject><subject>Health care</subject><subject>Health promotion</subject><subject>Health Status</subject><subject>Heart rate</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Intervention</subject><subject>Obesity</subject><subject>Outdoor air quality</subject><subject>Physical activity</subject><subject>Pilot Projects</subject><subject>Prevention programs</subject><subject>Resting</subject><subject>Selfmanagement</subject><subject>Selfmonitoring</subject><subject>self‐management</subject><subject>Smartphones</subject><subject>Smartwatches</subject><subject>Social networks</subject><subject>Software</subject><subject>Time use</subject><subject>Wearable computers</subject><subject>Wearable Electronic Devices</subject><subject>wearable technology</subject><subject>Weight control</subject><subject>Young Adult</subject><subject>Young adults</subject><issn>1527-6546</issn><issn>1547-5069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>ALSLI</sourceid><sourceid>HEHIP</sourceid><sourceid>M2S</sourceid><recordid>eNp1kc1OVDEYhhujEUQX3oBp4gYWB_rfqTtCBDQENrBuenpap5Oe07HtyWRccQlcI1diYdCFid30TfPkSb_vBeAjRse4nZPVNB9jIhl6BfYxZ7LjSKjXT5nITnAm9sC7UlYIIYElfQv2KJMKS4H3weZ26aDzPlhjtzB5aNM4umyDibCMJteNqXbpCtyEuoQG9jGlAa6zK2XO7vH-YUxTqCmH6Qf0ztT2-AWewnWIqcJspiGN4ZcbmnaqOcXYYs1N_h688SYW9-HlPgB3519vzy67q5uLb2enV52lnKJOWSKktwthreql6z3zi4EpMdCeedQmGHjPLBUIY2UNx4QSbwgjpGWDRU8PwOHOu87p5-xK1WMo1sVoJpfmoglXCkkqFGvo53_QVZrz1H6niVggyhnBvFFHO8rmVEp2Xq9zaIvaaoz0Uxu6taGf22jspxfj3I9u-Ev-WX8DTnbAJkS3_b9Jf7--2yl_A2uwlfQ</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Yen, Hsin‐Yen</creator><creator>Huang, Wen‐Hsin</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>4U-</scope><scope>7QJ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9194-1783</orcidid></search><sort><creationdate>202205</creationdate><title>The efficacy of commercial smartwatches with a blood pressure‐monitoring feature: A pilot randomized controlled trial</title><author>Yen, Hsin‐Yen ; Huang, Wen‐Hsin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-9c267fc86cc9b7ebf4f8d496d3b4f0761d5b4c360119ca51232fa2422a51a16b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>awareness</topic><topic>Blood Pressure</topic><topic>Chronic illnesses</topic><topic>Clinical trials</topic><topic>Disease prevention</topic><topic>Efficacy</topic><topic>Health behavior</topic><topic>Health care</topic><topic>Health promotion</topic><topic>Health Status</topic><topic>Heart rate</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Intervention</topic><topic>Obesity</topic><topic>Outdoor air quality</topic><topic>Physical activity</topic><topic>Pilot Projects</topic><topic>Prevention programs</topic><topic>Resting</topic><topic>Selfmanagement</topic><topic>Selfmonitoring</topic><topic>self‐management</topic><topic>Smartphones</topic><topic>Smartwatches</topic><topic>Social networks</topic><topic>Software</topic><topic>Time use</topic><topic>Wearable computers</topic><topic>Wearable Electronic Devices</topic><topic>wearable technology</topic><topic>Weight control</topic><topic>Young Adult</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yen, Hsin‐Yen</creatorcontrib><creatorcontrib>Huang, Wen‐Hsin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest research library</collection><collection>Sociology Database (ProQuest)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of nursing scholarship</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yen, Hsin‐Yen</au><au>Huang, Wen‐Hsin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The efficacy of commercial smartwatches with a blood pressure‐monitoring feature: A pilot randomized controlled trial</atitle><jtitle>Journal of nursing scholarship</jtitle><addtitle>J Nurs Scholarsh</addtitle><date>2022-05</date><risdate>2022</risdate><volume>54</volume><issue>3</issue><spage>324</spage><epage>331</epage><pages>324-331</pages><issn>1527-6546</issn><eissn>1547-5069</eissn><abstract>Purpose The purpose was to explore the efficacy of a commercial smartwatch with a blood pressure‐monitoring feature. Design A randomized controlled trial. Methods Sixty healthy young adults were recruited. Participants were randomly allocated to wear a commercial smartwatch, one with and one without a blood pressure‐monitoring feature for 12 weeks. Data were collected using Omron HEM‐907, Inbody 270S, and the International Physical Activity Questionnaire. Findings Results revealed a significant effect and group‐by‐time interaction on diastolic blood pressure. After 12 weeks in participants who wore a smartwatch with a blood pressure‐monitoring feature, the systolic and diastolic blood pressure and resting heart rate had decreased. Conclusion Using commercial smartwatches with a blood pressure‐monitoring feature is a feasible approach to support self‐management, increase awareness, and promote physical activity for health promotion, obesity and chronic disease prevention. Clinical relevance Wearable technologies may be an innovative strategy for preventing high blood pressure by continuous self‐monitoring and healthy behavior modifications.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>34791761</pmid><doi>10.1111/jnu.12740</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9194-1783</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1527-6546
ispartof Journal of nursing scholarship, 2022-05, Vol.54 (3), p.324-331
issn 1527-6546
1547-5069
language eng
recordid cdi_proquest_miscellaneous_2599073694
source Applied Social Sciences Index & Abstracts (ASSIA); Wiley; Social Science Premium Collection; Sociology Collection
subjects awareness
Blood Pressure
Chronic illnesses
Clinical trials
Disease prevention
Efficacy
Health behavior
Health care
Health promotion
Health Status
Heart rate
Humans
Hypertension
Intervention
Obesity
Outdoor air quality
Physical activity
Pilot Projects
Prevention programs
Resting
Selfmanagement
Selfmonitoring
self‐management
Smartphones
Smartwatches
Social networks
Software
Time use
Wearable computers
Wearable Electronic Devices
wearable technology
Weight control
Young Adult
Young adults
title The efficacy of commercial smartwatches with a blood pressure‐monitoring feature: A pilot randomized controlled trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A14%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20efficacy%20of%20commercial%20smartwatches%20with%20a%20blood%20pressure%E2%80%90monitoring%20feature:%20A%20pilot%20randomized%20controlled%20trial&rft.jtitle=Journal%20of%20nursing%20scholarship&rft.au=Yen,%20Hsin%E2%80%90Yen&rft.date=2022-05&rft.volume=54&rft.issue=3&rft.spage=324&rft.epage=331&rft.pages=324-331&rft.issn=1527-6546&rft.eissn=1547-5069&rft_id=info:doi/10.1111/jnu.12740&rft_dat=%3Cproquest_cross%3E2680354215%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3530-9c267fc86cc9b7ebf4f8d496d3b4f0761d5b4c360119ca51232fa2422a51a16b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2680354215&rft_id=info:pmid/34791761&rfr_iscdi=true